169 related articles for article (PubMed ID: 30678449)
1. PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients.
Kazim Z; Wahabi K; Perwez A; Lal P; Rizvi MA
Asian Pac J Cancer Prev; 2019 Jan; 20(1):269-276. PubMed ID: 30678449
[TBL] [Abstract][Full Text] [Related]
2. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India.
Siddiqui S; Akhter N; Deo SV; Shukla NK; Husain SA
Breast Cancer; 2016 Nov; 23(6):922-931. PubMed ID: 26754093
[TBL] [Abstract][Full Text] [Related]
3. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation.
Sadeq V; Isar N; Manoochehr T
Med Oncol; 2011 Jun; 28(2):420-3. PubMed ID: 20237868
[TBL] [Abstract][Full Text] [Related]
4. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
5. PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: two hits on the gene?
Hühns M; Salem T; Schneider B; Krohn M; Linnebacher M; Prall F
Oncol Rep; 2014 May; 31(5):2236-44. PubMed ID: 24647592
[TBL] [Abstract][Full Text] [Related]
6. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
7. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
[TBL] [Abstract][Full Text] [Related]
8. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
9. Assessment of epigenetic alterations and in silico analysis of mutation affecting PTEN expression among Indian cervical cancer patients.
Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Bin Hafeez Z; Tiwari RR; Wahabi K; Gandhi G; Alam Rizvi MM
J Cell Biochem; 2019 Sep; 120(9):15851-15866. PubMed ID: 31074114
[TBL] [Abstract][Full Text] [Related]
10. Altered transcription and expression of PTEN in breast tumors: is it regulated by hypermethylation?
Shetty PJ; Pasupuleti N; Chava S; Nasaruddin K; Hasan Q
Breast Dis; 2011; 33(1):27-33. PubMed ID: 21846942
[TBL] [Abstract][Full Text] [Related]
11. Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients.
Real SAS; Parveen F; Rehman AU; Shaik R; Deo SVS; Husain SA
Mutat Res; 2019 Nov; 816-818():111677. PubMed ID: 31557600
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population.
Rizvi MM; Alam MS; Ali A; Mehdi SJ; Batra S; Mandal AK
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1255-62. PubMed ID: 21698421
[TBL] [Abstract][Full Text] [Related]
13. PTEN promoter is methylated in a proportion of invasive breast cancers.
Khan S; Kumagai T; Vora J; Bose N; Sehgal I; Koeffler PH; Bose S
Int J Cancer; 2004 Nov; 112(3):407-10. PubMed ID: 15382065
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
15. Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients.
Wahabi K; Perwez A; Kamarudheen S; Bhat ZI; Mehta A; Rizvi MMA
BMC Cancer; 2019 Aug; 19(1):820. PubMed ID: 31429726
[TBL] [Abstract][Full Text] [Related]
16. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.
Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Gandhi G; Rizvi MMA
Tumour Biol; 2017 Jun; 39(6):1010428317703635. PubMed ID: 28631565
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
20. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
Yari K; Payandeh M; Rahimi Z
Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]